They asked a tough question that needs to be addressed. It's as necessary as "is there a place for assisted suicide?" question.

They proposed 1) Address large markets; 2) Address disorders with high incidence; and 3) Constant innovation and portfolio expansion.

Does that sound like to you they proposed not curing patients?